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Background: Glucose-regulated proteins (GRP) are induced in the cancer microenvironment to promote tumor
survival, metastasis and drug resistance. AST was obtained from the medicinal plant Astragalus membranaceus,
which possesses anti-tumor and pro-apoptotic properties in colon cancer cells and tumor xenograft. The present
study aimed to investigate the involvement of GRP in endoplasmic reticulum (ER) stress-mediated apoptosis during
colon cancer development, with focus on the correlation between AST-evoked regulation of GRP and calpain
activation.
Methods: The effects of AST on GRP and apoptotic activity were assessed in HCT 116 human colon
adenocarcinoma cells. Calpain activity was examined by using a fluorescence assay kit. Immunofluorescence
staining and immunoprecipitation were employed to determine the localization and association between calpains
and GRP. GRP78 gene silencing was performed to confirm the importance of GRP in anticancer drug activities. The
modulation of GRP and calpains was also studied in nude mice xenograft.
Results: ER stress-mediated apoptosis was induced by AST, as shown by elevation in both spliced XBP-1 and CHOP
levels, with parallel up-regulation of GRP. The expression of XBP-1 and CHOP continued to increase after the peak
level of GRP was attained at 24 h. Nevertheless, the initial increase in calpain activity as well as calpain I and II
protein level was gradually declined at later stage of drug treatment. Besides, the induction of GRP was partly
reversed by calpain inhibitors, with concurrent promotion of AST-mediated apoptosis. The knockdown of GRP78 by
gene silencing resulted in higher sensitivity of colon cancer cells to AST-induced apoptosis and reduction of colony
formation. The association between calpains and GRP78 had been confirmed by immunofluorescence staining and
immunoprecipitation. Modulation of GRP and calpains by AST was similarly demonstrated in nude mice xenograft,
leading to significant inhibition of tumor growth.
Conclusions: Our findings exemplify that calpains, in particular calpain II, play a permissive role in the modulation
of GRP78 and consequent regulation of ER stress-induced apoptosis. Combination of calpain inhibitors and AST
could exhibit a more pronounced pro-apoptotic effect. These results help to envisage a new therapeutic approach
in colon cancer by targeting calpain and GRP.
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Endoplasmic reticulum (ER) is the place for calcium
storage and transmembrane protein synthesis, folding
and maturation [1]. Apoptosis can be triggered by ER
stress due to accumulation of misfolded proteins in the
ER. On the one hand, prolonged or severe ER stress
promotes several pro-apoptotic factors that result in
apoptosis, while on the other hand it also activates a set
of signaling pathway called unfolded protein response
(UPR) to prevent apoptosis [2]. Transduction signals in-
cluding CCAAT/enhancer-binding protein-homologous
protein (CHOP), pro-apoptotic Bcl-2 family members,
caspase 12 and c-Jun N-terminal kinase (JNK) all involve
in ER stress-induced cell death [3], while UPR leads to
adaptation for survival [4]. One of the protective mecha-
nisms of body cells to adapt to ER stress is induction of
the glucose-regulated protein (GRP) family members
through glucose starvation. GRP78, also referred to as
BiP (immunoglobulin heavy-chain binding protein), re-
sides primarily in the ER, binds to calcium and serves
as an ER stress signaling regulator [5]. Alternatively,
GRP94 is the most abundant glycoprotein in the ER in
vertebrates. Both GRP78 and GRP94 function as mo-
lecular chaperones that can bind to misfolded proteins
and unassembled the complexes to protect cells against
death [5,6]. The anti-apoptotic property of GRP could
lead to cancer progression and drug resistance in neo-
plastic cells [7,8]. Another study also showed that GRP
may promote tumor cell proliferation and metastasis,
which have major implications in the prognosis and
treatment of cancer [9]. Down-regulation of GRP78 in
colorectal cancer cells facilitates the sensitization to
paclitaxel-induced apoptosis [10]. Several natural com-
pounds including genistein and green tea constituents
have been proven to strengthen the anticancer ability
through GRP78 inhibition [11]. These observations have
provided evidence that inhibitors of GRP78 can be used
in combination with standard chemotherapeutic agents
to enhance drug efficacy against cancer development.
Calcium has been known to be crucial in the regu-
lation of apoptotic signaling [12]. Elevation of intra-
cellular calcium level activates several pro-apoptotic
proteins including phosphatase calcineurin and a family
of calcium-dependent cysteine proteases called calpains
[13]. Calpains can be found in all eukaryotes with two
ubiquitous isoforms, μ-calpain and m-calpain (also
known as calpains I and II, respectively). Metastasized
tumors from human renal cell carcinoma were found to
have overexpression of calpain I [14], whereas epi-
genetic activation of calpain II could be essential in
determining the invasiveness of human prostate cancer
cells [15]. Release of calcium from the ER would lead to
calpain activation. Calcium-activated calpains are trans-
located from the cytosol to the cell membrane, wherethey associate with caspases to regulate apoptosis. These
activated calpains trigger degradation of the plasma mem-
brane and subsequently result in the loss of cellular integ-
rity [16]. Calpains are involved in the execution phase of
apoptosis when induced by certain stimuli [17]. The actual
role of calpain can vary depending on the type and sever-
ity of the apoptotic stimulus even within the same cell line
[18,19]. In general, calcium-activated calpains are translo-
cated from the cytosol to the cell membrane, where they
crosstalk with caspases to regulate apoptosis. Based on the
available evidence, apoptotic regulation by calpains can be
both positive and negative [20]. It was reported that cal-
pain II can cleave procaspase 12 to generate active cas-
pase 12, which is capable of directly activating caspase 3
that leads to apoptosis [21]. The role of calpains in
apoptosis is also indicated by a growing list of its sub-
strates, including p53, poly(ADP-ribose) polymerase
(PARP), Bax, Bid, apoptosis-inducing factor (AIF) and
several cytoskeletal proteins [22]. Recent research has
shown that inhibition of calpain activity and Bax defi-
ciency would promote the enhancement of autophagy
in hepatocellular carcinoma. It has been suggested that
calpain could act as a molecular link between autophagy
and apoptosis that reveals a possible crosstalk between
the two closely related processes [23]. Other than pro-
motion of cell death, calpains also participate in the
regulation of adhesion complexes that are important in
cell migration and motility [24]. Based on the above ob-
servations, calpains have already been regarded as a po-
tential new target for anti-cancer drugs.
It had been recently demonstrated in our laboratory
that AST, the total saponins being isolated from the root
of the medicinal herb Astragalus membranaceus possess
anti-tumorigenic activity in several cancer cell types in-
cluding hepatocellular carcinoma (HCC), colon cancer
cells and xenografts [25-27]. AST facilitates growth in-
hibition and promotes apoptosis in HepG2 cells through
modulation of an ERK-independent NF-κB signaling
pathway [25]. AST could also induce extrinsic apoptotic
cascade and cause cell cycle arrest in HT-29 cells by
modulation of both mTOR and ERK signaling, with
concomitant inhibition of NF-κB in the latter mecha-
nism [28]. Last but not least, we have revealed that
non-steroidal anti-inflammatory drug activated gene
(NAG-1) is a potential molecular target of AST in its
anti-tumorigenic and pro-apoptotic actions [26]. The
aim of the present study was to explore whether AST is
able to suppress GRP and regulate calpains in human
colon cancer cells, which could contribute to its anti-
tumor property. Close interactions between GRP and
calpains would promote apoptosis of cancer cells.
Hence, a new and effective therapeutic intervention of
colon cancer growth with known molecular targets
could be established in the coming future.
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Materials
Dulbecco’s modified essential medium, fetal bovine serum
(FBS), penicillin and streptomycin were supplied by Gibco
(Carlsbad, CA). The enhanced chemiluminescence (ECL)
detection kit was purchased from Amersham Biosciences
(Piscataway, NJ). 3-[4, 5-dimethylthiazol-2-yl) 2,5-diphe-
nyltetrazolium bromide (MTT) and other chemicals were
obtained from Sigma-Aldrich (St. Louis, MO) unless spe-
cified. The following antibodies were used: anti-GRP78,
anti-GRP94, anti-calpain I and anti-calpain II (Santa
Cruz Biotechnology, Santa Cruz, CA); anti-caspase 3,
(Upstate Biotechnology, Charlottesville, VA); anti-PARP
(BD Pharmingen, San Jose, CA); anti-β-actin (Sigma-
Aldrich, St. Louis, MO).
Cell culture
Human colorectal carcinoma cells HCT116 were obtained
from the American Type Culture Collection (ATCC;
Manassas, VA). Cells were grown in 75-cm2 flasks and in-
cubated at 37°C under 5% CO2 atmosphere in Dulbecco’s
Modified Eagle’s medium (DMEM) supplemented with
10% FBS plus 1% penicillin and streptomycin (Invitrogen,
Carlsbad, CA).
Preparation of AST
Radix Astragalus membranaceus (Fisch.) Bunge var.
mongolicus was obtained from the province of Shanxi,
China through the MMCHY Chinese Medicine Specialty
Clinic and Good Clinical Practice Centre of our institu-
tion. Microscopic and chromatographic analyses as well
as DNA fingerprinting were carried out to determine the
authenticity and to assess the quality of raw herb in the
Quality Assurance Laboratory of the School of Chinese
Medicine, Hong Kong Baptist University. To ensure
consistency between batches, voucher specimens will be
kept at the herbarium centre for future reference. AST
was extracted according to the method as described pre-
viously. In brief, 500 g of crude herb was refluxed in
methanol for 1 h. n-Butanol was then added to the re-
constituted residue for phase separation to obtain the
total Astragalus saponins [29]. Butanol was removed in
the rotary evaporator. The resulting residue was recon-
stituted with distilled water and lyophilized into dry
powder.
Assessment of cell viability by MTT assay
Upon drug treatment, the cell viability assay was
employed to determine the effective concentration of
AST. Cell viability of HCT116 was measured by using
the 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction method, which involved the
reduction of yellow MTT into purple insoluble formazan
product by the mitochondrial reductase enzymes ofviable cells. HCT116 cells (3.0 × 103 cells) were plated in
96 well plates in DMEM and treated with AST for 24,
48 or 72 h, followed by incubation with MTT (5 mg/ml)
for another 3 h at 37°C. Control cells received DMEM
treatment only. DMSO was then used to dissolve the
formazan product for spectrophotometric analysis at the
wavelength of 540 nm.
Western immunoblotting
Protein levels after drug treatments were evaluated using
Western immunoblotting. Cells were seeded at a density
of 3.5 × 105 in 60-mm dishes. After drug treatment at vari-
ous time points, cells were lysed in RIPA buffer (pH 7.4)
containing 50 mM Tris, 150 mM NaCl, 0.5% deoxycho-
late, 0.1% SDS, 2 mM EDTA, 0.1% Triton X-100, 10% gly-
cerol, 1 mM phenylmethylsulfonyl fluoride and 10 μg/ml
aprotinin. After centrifugation at 14,000 × g for 10 min at
4°C, the insoluble materials were removed and proteins
were quantified using Coomassie Plus Protein Assay Re-
agent kit (Pierce, Rockford, IL). Total cellular proteins
(20–40 μg) in the cell lysate were separated by 8-15% SDS
polyacrylamide gel electrophoresis and transferred onto a
nitrocellulose membrane. Protein bands were detected by
incubating the membrane in respective primary antibodies
(1:1000) and secondary antibodies (1:2000) conjugated
with horseradish peroxidase, and visualized by adding
enhanced chemiluminescence (ECL) reagents (Amersham
Biosciences; Piscataway, NJ). Results were analyzed by
using the Quantity One version 4.4.1 Basic software
(BioRad, Hercules, CA).
Immunofluorescence staining
The immunofluorescence staining was used to examine
the co-localization of GRP78 and calpain II. HCT116
cells were grown on glass coverslips treated with AST
for 48 h. After treatment, cells were washed with cold
phosphate buffered saline (PBS) twice and fixed in 4%
paraformaldehyde for 10 min. Following fixation, cells
were washed with PBS for three times and then perme-
abilized with ice-cold methanol at −20°C for 5 min. Cells
were then washed with PBS for three more times before
incubating with primary antibodies (1:100 dilution) at
4°C. On the next day, the slides were stained with cor-
responding FITC-conjugated secondary antibodies for
2 h at room temperature. The nuclei were then stained
with the DNA binding dye 4′,6-diamidino-2-phenylin-
dole dihydrochloride (DAPI) for 10 min and examined
under fluorescence microscopy (Leica DMI3000B, Leica
Microsystems, Wetzlar, Germany).
Immunoprecipitation
The association and dynamic interaction between GRPs
and calpains were studied using immunoprecipitation.
After drug treatment, HCT116 cells were harvested and
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50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 0.1% NP-40, 1 mM phenylmethylsulfonyl
fluoride and 10 μg/ml aprotinin. Supernatant was col-
lected after centrifugation at 14,000 × g at 4°C. The pro-
tein G sepharose resins were pre-cleared and restored to
50% slurry with IP buffer. Antibody (1 μg) was then
added to each prepared sample and rocked overnight at
4°C. The immunocomplex was captured by adding pre-
cleared protein G sepharose beads slurry. After incuba-
tion at 4°C for 1 h, the sepharose resins were collected
by pulse centrifugation at 4°C (10 s at 14,000 × g) and
washed twice with ice-cold PBS. Proteins were boiled in
5× sample loading buffer for 5 min to dissociate the
immunocomplexes from the sepharose resins, and stored
at −20°C for subsequent use.
siRNA transfection
We performed the siRNA transfection so as to confirm
the involvement of GRP78 in AST-mediated. Cells were
transfected with GRP78 siRNA duplexes containing a pool
of 3 specific 19–25 nt siRNAs targeting GRP78 (Santa
Cruz Biotechnology). A non-targeting 20–25 nt scramble
siRNA (Scr) was used as negative control. In brief, control
(medium-treated) or AST-treated (80 μg/ml) HCT116
cells were cultured at 60% confluence and transfected
with GRP78 siRNA or Scr for 24 h using Lipofectamine
(Invitrogen) according to the manufacturer’s instruction.
Following gene silencing, Western immunoblotting was
conducted to assess target proteins in cells.
Colony formation assays
Colony formation assay was based on the ability of a
single cell to grow into a colony and was used to study
the effectiveness of specific agents on the survival and
proliferation of cells. After gene silencing of GRP78, cells
were seeded in six-well plates at the density of 200 cells/
well and cultured in the absence or presence of AST for
14 days. Medium was changed every 4 days to maintain
the viability of cells and the propagation to form visible
colonies. The colonies were fixed with methanol-acetic
acid (3:1), and stained with 1% crystal violet for 2 h at
room temperature. The number of colonies in each well
was counted.
Calpain activity assay
Calpain Activity Assay kit involved fluorometric detection
of protease calpain activity in the cell, in which only acti-
vated calpain in cytosol was detected (Abcam, Cambridge,
MA). In brief, HCT116 cells (1 × 106) were suspended in
100 μl of extraction buffer and centrifuged at 10,000 × g
for 1 min. Cell lysate (~200 μg) was diluted in 85 μl of
extraction buffer. For the positive control, 2 μl of active
calpain was added to 85 μl of extraction buffer. Theuntreated cell lysate was used as negative control. After
incubation at 37°C for 1 h, the absorbance of samples were
read in a fluorescence spectrometer equipped with a
400 nm excitation filter and a 505 nm emission filter
(PerkinElmer LS55, Waltham, MA).
Tumor xenograft in nude mice
The involvement of caplain and GRP in AST-mediated
modulation of colon cancer development was studied
using tumor xenograft. All the experimental procedures
involving laboratory animals in this original research
were approved by the Committee on the Use of Human
& Animal Subjects in Teaching & Research (HASC) of
our home institution, and had been performed according
to international, national and institutional regulations.
Cell suspension was obtained by trypsinization of con-
fluent HCT116 cells. Balb/c-nu/nu mice were randomly
assigned into control (vehicle) and AST (100 mg/kg, p.o.
once daily for 14 days) treatment groups (n = 6-8). Ani-
mals were anesthetized and cell suspension (2 × 106 in
100 μl medium) was injected subcutaneously near the
right flank of each animal. Tumors became palpable
10 days after implantation, when vehicle or drug treat-
ment was commenced. Tumor volume was measured
every other day by using a digital caliper and calculated
as (length × width2)/2. The percentage of change in
tumor volume with respect to the measured volume on
day 10 (100%) was determined until the end of the ex-
perimental period. Body weight as well as the amount of
food and water intake in all animals was monitored as
assessment of possible drug toxicity. Any mortality du-
ring the course of study would also be noted. The mass
of the tumor in each animal was assessed at the end of
experiment on day 24. Protein levels of GRP78, GRP94,
calpain I and calpain II were determined in the excised
tumor samples by using Western immunoblotting.
Statistical analysis
Results were expressed as mean ± SEM. Statistical sig-
nificance was determined by either one- or two-way ana-
lysis of variance (ANOVA) followed by Tukey post-hoc
test (SPSS version 10.0, Chicago, IL), whereas p <0.05
was deemed to be significant.
Results
AST induced ER stress-mediated apoptosis
In order to explore the involvement of ER stress and UPR
activation in AST-induced apoptosis, the drug effects on
GRP78 and GRP94 (the protective arm of the UPR),
CHOP (also known as the growth arrest- and DNA
damage-inducible gene GADD153) as well as splicing of
XBP-1 (the pro-apoptotic component of ER stress) were
examined. Figure 1A illustrates that AST elicited an ER
stress response, as shown by the enhanced expression of
Figure 1 Effects of AST on UPR activation (A) and ER
stress-induced apoptosis (B) on HCT116 colon cancer cells.
HCT116 colon cancer cells were treated with AST (80 μg/ml) for
different time intervals (4–96 h). Specific antibodies against GRP78,
GRP94, XBP-1s and CHOP were used in Western immunoblotting
to detect the expression of different proteins. Data shown are
representative immunoblots with similar findings, normalized by
β-actin. Blots were scanned and optical densities were determined
using the Quantity One software. Each histogram represents mean ±
SEM of four independent experiments. *p <0.05 compared with the
protein level at zero time.
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imum GRP expression was attained at 24 h and began to
decline gradually, suggesting that prolonged ER stress
caused failure in the ER recovery process, leading to the
initiation of apoptotic cell death. Upon continuous AST
treatment, the expression of CHOP and spliced XBP-1
kept increasing even after the peak of GRP expression
were reached (Figure 1B). These results exemplify that at
early stage of AST treatment, the response of colon cancer
cells to ER stress was initially cytoprotective. Nonetheless,
upon prolonged drug treatment when cells were challenged
by overwhelming amount of ER stress, apoptosis would be
induced, along with concomitant down-regulation of GRP.
Involvement of calpains in AST-induced ER stress-
mediated apoptosis
We further investigated the signaling pathway of ER
stress-mediated apoptosis by studying the effect of AST
on the activation of calpains, the indicator of calcium
homeostasis disruption. Calpain activity (Figure 2A) as
well as calpain I and II protein expression (Figure 2B)
were elevated following AST treatment. The induced ex-
pression of calpain proteins was gradually declined at
later stage of drug treatment after 24 h. These findings
may be explained by some reports stating that lack of
calpain activity could sensitize cells to programmed cell
death due to a variety of stimuli, including growth fac-
tors and nutrient starvation [30].
In order to examine the role of calpains in AST-induced
apoptosis, regulation of GRP was assessed in the presence
of calpain inhibitors. As shown in Figure 3A, the induc-
tion of GRP78 and GRP94 by AST was significantly sup-
pressed by the calpain inhibitor ALLN, implicating the
enhancement of ER stress-associated apoptosis. This was
confirmed by the observation of increased PARP cleavage
and caspase-3 activation (Figure 3B). Similar results were
obtained by using another calpain inhibitor ALLM (data
not shown). We have shown here that calpain inhibitors
could potentiate the pro-apoptotic effect of AST through
down-regulation of GRP, leading to augmentation of anti-
cancer drug activity. These findings provide evidence on
the fact that sensitization of colon cancer cells to ER
stress-induced apoptosis by inhibition of calpain is asso-
ciated with GRP modulation.
Co-localization and dynamic interaction between calpain
II and GRP78
In order to elucidate the regulatory role of calpain on
GRP during ER stress-induced apoptosis, immunofluo-
rescence staining was performed. Under our experi-
mental condition, a significant association was observed
between calpain II and GRP78 after 24 h of drug treat-
ment (Figure 4A). There was only a minimal amount of
calpain II signal being detected in the cytoplasm and
Figure 2 AST modulates calpain activity (A) and calpain protein
expression on HCT116 colon cancer cells (B). HCT116 colon
cancer cells were treated with AST (80 μg/ml) for different time
intervals (4–96 h). Calpain activity was measured by employing the
calpain activity assay using fluorescent calpain substrate Ac-LLY-AFC.
Calpain I and II protein levels in AST-treated cells were assessed by
Western immunoblotting using specific antibodies. Data shown are
representative immunoblots with similar findings, normalized by
β-actin. Blots were scanned and optical densities were determined
using the Quantity One software. Each histogram represents mean ±
SEM of four independent experiments. *p <0.05 compared with the
protein level at zero time.
Figure 3 Calpain inhibitor attenuates GRP induction (A) and
promotes AST-induced apoptosis (B). HCT116 colon cancer cells
were either incubated with culture medium only (control) or pre-treated
with the calpain inhibitor ALLN for 30 min. AST (80 μg/ml) was then
administrated to cells and incubated for 24 h in all groups except the
ALLN alone group. Specific antibodies against GRP78, GRP94, cleaved
caspase-3 and PARP were used in Western immunoblotting to detect
the expression of different proteins. Data shown are representative
immunoblots with similar findings, normalized by β-actin. Blots were
scanned and optical densities were determined using the Quantity
One software. Each histogram represents mean ± SEM of four
independent experiments. *p <0.05 compared with the control
without drug treatment; #p <0.05 compared with cells treated with
ALLN alone.
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crease of expression could be observed in the cell mem-
brane of drug-treated cells. Likewise, the expression of
GRP78 was relatively weak in untreated control cells when
compared with the induction of cell membrane expression
after drug treatment. The enhancement of signal in the
cell membrane indicates that AST-induced ER stress couldfacilitate GRP78 localization on the cell surface. The inter-
action between GRP78 and calpain II had been indicated
as shown by the increased co-localization after drug treat-
ment, especially on the cell membrane. In order to
confirm the results from immunofluorescence staining,
immunoprecipitation was performed, followed by Western
immunoblotting. Figure 4B demonstrates that endogenous
GRP78 was co-immunoprecipitated with calpain II. The
Figure 4 Effects of AST on the localization of (A) and interaction between calpain II and GRP78 (B) were determined. HCT116 cells were
treated with AST (80 μg/ml) for 24 h. Co-localization of calpain II and GRP78 were detected in control [C] and drug-treated cells. Specific
immunofluorescence antibodies against calpain II and GRP78 were used, while DAPI acted as nuclear stain. Green and red fluorescence
indicates the presence of calpain and GRP78, respectively in the cells and blue color represents the DAPI-stained nucleus. Interaction between calpain
II and GRP78 was further detected by immunoprecipitation [IP]. HCT116 cells were treated with AST (80 μg/ml) for 24 or 48 h. Immunoprecipitated
proteins were collected and subject to Western immunoblotting [IB]. Data shown are representative immunoblots with similar findings. IgG was used
as precipitating antibody in the negative control.
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should be specific because this complex was not observed
when using control IgG as the precipitating antibody. The
amount of GRP78 that was co-precipitated with calpain II
increased after 24 h of drug treatment. This observation is
coherent with the increased amount of activated calpain II
in the precipitates, presumably due to increased cellular
contents of the calpains. The findings from immuno-
fluoresence staining and immunoprecipitation have re-
vealed a dynamic interaction between GRP78 and calpain
II in human colon cancer cells following AST treatment.
Suppression of GRP78 by small interfering RNA enhances
sensitivity of HCT116 colon cancer cells
To further validate the role of GRP78 in ER stress-
induced apoptosis, the gene expression of GRP78 was
silenced. Figure 5A exemplifies a significant knock-down
of GRP78 (by more than 70%) after 24 h of siRNA trans-
fection, without alteration of apoptosis (indicated by the
unchanged level of cleaved caspase-3 and PARP clea-
vage). Nonetheless, GRP78 expression had been increased
by more than 6 folds following AST treatment in GRP78-silenced cells, with concurrent increase in apoptosis (with
increased PARP cleavage and caspase-3 activation). These
results demonstrate that GRP78 knock-down by gene
silencing would result in a substantial increase in the
sensitivity of colon cancer cells to apoptosis. The effect of
GRP78 gene silencing on colony formation was further
assessed (Figure 5B). Cell colony formation (according to
both number and size) was significantly reduced in AST-
treated GRP78-silenced cells when compared to either
control GRP78-silenced cells or AST-treated cells without
gene silencing.
Effects of AST on GRP, calpains and tumor growth in
HCT116 xenografted nude mice
In order to confirm that AST could modulate tumor de-
velopment by regulating calpain-mediated GRP level, the
expression of GRP and calpains was assessed in HCT116-
xenografted nude mice. Results show that AST treatment
markedly reduced the expression of GRP78, GRP94 and
calpain II in colonic tumor tissues, with less significant
downregulation of calpain I (Figure 6A and B). Besides,
there was also a significant inhibition of tumor growth
Figure 5 Effects of GRP78 silencing on AST-induced apoptosis
(A) and colony formation (B). After 24 h of transfection with
GRP78 siRNA or scrambled control siRNA [Scr], the protein levels of
GRP78, cleaved caspase 3 and PARP were determined in HCT116
cells with or without AST treatment (80 μg/ml for 24 h) by Western
immunoblotting. Data shown are representative immunoblots from
four independent experiments with similar findings, normalized by
β-actin. Blots were scanned and optical densities were determined
using the Quantity One software. Alternatively, native or GRP78
gene-silenced HCT116 cells were cultured in six-well plates at the
density of 200 cells/well at 37°C in 5% CO2 atmosphere for 3 weeks
with or without AST treatment (80 μg/ml) in the last 14 days to
determine colony formation.
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(Figure 6C), which together verifies our in vitro data.
Discussion
ER has been designated as a major therapeutic drug target
due to its vital involvement in apoptotic execution [31].
Perturbation of ER homeostasis plays critical roles in
tumorigenesis, and therapeutic modulation of ER chape-
rones and/or UPR components presents potential anti-
tumor treatment. Nevertheless, excessive activation of the
ER stress pathways in hypoxic tumor cells has been shown
to render them more sensitive to proteasome inhibitors,
resulting in increased cytotoxicity [32]. In the present
study, AST has been proven to facilitate ER stress-induced
apoptosis through regulation of GRP78. It fact, most of
the GRP in tumor cells are engaged in the formation of
multi-chaperone complexes, an event not being observed
in normal cells [33]. Evidence has shown that high levels
of GRP78 and GRP94 were detected in breast and colon
cancer [6]. Cell surface GRP78 has been identified as an
important tumor cell signaling and viability regulator byforming complexes with a variety of cell-surface proteins
to regulate proliferation and cell viability [34,35]. Intracel-
lular GRP78 possesses pro-survival and anti-apoptotic
functions while the cell surface GRP78 serves as a re-
ceptor for pro-apoptotic ligands such as Kringle (K5) and
Par-4, promoting apoptosis [36,37]. In addition, it is
known that prolonged ER stress may activate specific
mechanisms for GRP78 to aggressively interact with other
pro-apoptotic proteins such as caspase 7 and T-cadherin
[38,39]. In the present study, AST has been proven to fa-
cilitate ER stress-induced apoptosis through regulation of
GRP78. An early increase of GRP78 level plays an essen-
tial role in the protection of cells from apoptosis during
ER stress [37,38]. In particular, a marked increase of
GRP78 expression in the cell membrane of drug-treated
cells could be observed, while gradual decrease of GRP78
in prolonged ER stress caused failure in the ER recovery
process and led to the initiation of apoptotic cell death.
Until now, the mechanism of GRP78 trafficking from the
ER to the cell surface is not well understood. Nevertheless,
it is plausible that ER luminal GRP78, either by itself or
through interaction with other proteins being translocated
into the ER, could be redistributed to the cell surface by
escaping the ER retrieval mechanism [40]. In addition,
GRP regulation may require a close working relationship
with the tumor suppressor gene p53 to promote apoptosis
under different tumor microenvironments [41]. Mutation
of p53 could however affect both caspase and calpain
functions in the control of apoptosis [42]. This could ex-
plain why AST-induced downregulation of GRP was
largely attenuated in another colonic cancer cell line with
mutated p53 gene (Additional file 1: Figure S1). It is to
our surprise that silencing of GRP78 alone did not impose
a significant promotion of apoptosis in non-drug-treated
HCT116 colon cancer cells. Nonetheless, suppression of
GRP78 protein expression by siRNA deactivated UPR and
potentiated AST-induced apoptosis in the cells. This has
been further verified by using colony formation assay.
GRP78 is known to function as a Ca2+-binding protein
in the ER thereby preventing Ca2+ efflux into the cytosol
and providing a buffer against induced increases in
cytosolic Ca2+ levels, which could result in cell death.
On the other hand, increased cytosolic calcium will
cause the activation of calpain and its membrane trans-
location, where they were associated with caspases, such
as caspase-12, to regulate apoptosis [43]. Furthermore,
it is known that GRP78 could form a complex with
caspase-7 and −12 and prevents release of caspase-12
from the ER [44]. Here, we have unveiled a dynamic
interaction between GRP78 and calpain II following
treatment of pro-apoptotic agent. GRP78 is a physio-
logical substrate for calpain II, which will be activated at
the ER membrane by interacting with GRP78 upon drug
stimulation. Further studies are required to prove
Figure 6 AST modulates the protein expression of GRP (A) and calpains (B) in tumor tissues, and inhibits tumor growth in HCT116-
xenografted nude mice (C). HCT116 tumor cells (2 × 106) were injected subcutaneously to Balb/c-nu/nu mice near the right flank on day 0. Drug
treatment (AST: 100 mg/kg) commenced from day 10 when tumors became palpable, and the tumor growth in xenografted animals were monitored
every other day. Animals in each treatment group (n = 6-8) were sacrificed on day 24 of the experiment, when the tumor tissues were excised to
assess the protein expression of GRP78, GRP94, calpain I and calpain II by using Western immunoblotting. Percentage change in tumor volume in each
treatment group from day 10 to day 24 was measured and compared with respect to the volume on day 10 (100%). Representative immunoblots
were obtained from independent experiments with similar findings, normalized by β-actin. Blots were scanned and optical densities were determined
using the Quantity One software. The histogram represents mean ± SEM of four independent experiments. *p <0.05 and **p <0.01 compared with
untreated control mice.
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calpain II through caspases. However, a similar study
showed that GRP94 is a physiological substrate for cal-
pain. Calpain has been demonstrated to be activated at
the ER membrane, where it interacts with GRP94, re-
sulting in its specific proteolytic cleavage as the cells
undergo apoptosis [45]. Our results have indicated that
the peak level of GRP78 was attained after 24 h of ER
stress. This is in fact in line with a previous report that
the most significant increase in caspase 3 activity was
observed at 24 h of drug-induced ER stress, simultan-
eous to increased caspase 12 enzymatic activity [46].
They explained that caspase 12 was first initially pro-
cessed by calpain by removing the CARD-containingpro-domain to produce a 38-kDa fragment. The above
discovery implicates that sensitization of colon cancer
cells to ER stress-induced apoptosis by regulation of
calpain is associated with blockade of prolonged GRP78
induction. Calpain is implicated in anti-apoptotic func-
tions via stimulation of ERK pathway in neurons [47] as
well as NF-κB survival pathway following treatment of
tumor necrosis factor [48]. Proteasome inhibitor PS-341
(bortezomib)-induced IκBα degradation was prevented by
calpain inhibition, leading to an enhancement of the anti-
cancer activity [49]. Silencing of calpain II resulted in a
partial restoration of irinotecan sensitivity in drug-
resistant colorectal cancer cells [50]. Therefore, we have
determined that combination of pharmacological calpain
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come a new therapeutic strategy for human colon cancer
treatment through promotion of apoptosis. The induction
of GRPs following exposure to AST was significantly sup-
pressed by the calpain inhibitors. This part of result has
suggested that calpain activation was an early event and
may precede the disruption of the ER. It was possible that
the calpain inhibitor interfered with the induction of GRPs
and the subsequent apoptotic response. In addition, re-
sults from the current work have revealed that combin-
ation of AST and calpain inhibitors actually resulted in
augmentation in the induction of ER stress-associated
apoptosis. In spite of this, some transmembrane proteins
that promote cancer cell migration, invasiveness and me-
tastasis by provoking cell motility were found to be down-
regulated by calpain-mediated proteolytic degradation
[51]. Calpain II was overexpressed in colorectal cancer bi-
opsy samples and played an important role in early stages
of the metastatic process [52]. Elevated calpain activity is
necessary for the remodeling of focal adhesion, and cell
migration of oncoproteins, in which they play distinctive
roles in oncogenic events induced by individual trans-
forming proteins [53]. It was shown that inhibition of cal-
pain activity could modulate cell migration through
stabilized peripheral focal adhesions and by decreasing the
rate of cell membrane detachment, all aiming to gain con-
trol of cancer cell metastasis [54]. Other than being self-
driven, calpains could also interact with other signaling
pathways in the regulation of essential cellular functions
and diseases, including cancer. It was reported that cal-
pain small subunit 1 interacts with class IA phosphoinosi-
tide 3-kinases (PI3K) to induce a negative regulation of
the PI3K-Akt pathway [55]. The p110α, p110β and p85s
subunits of PI3K are substrates of calpains I and II, with
preferential cleavage of p110, which leads to inhibition of
PI3K activity and suppressed downstream protein expres-
sion. This calpain-PI3K modulation plays an important
role in the regulation of PI3K-Akt signaling, particularly in
response to stress such as serum starvation. We have pre-
viously reported that AST inhibits colon cancer growth by
its interaction with the PI3K-Akt-mTOR pathway [26,28],
which may correlate with the complicated modulation of
calpains. AST can be used as an adjuvant in combination
with other orthodox chemotherapeutic drugs to reduce
the side effects of the latter compounds [27]. We have also
demonstrated that AST could exert anti-carcinogenic
effects against colon, liver and gastric cancers through dif-
ferent mechanisms [25,28]. Besides, AST possesses anti-
angiogenic and anti-invasive properties in colon [56] and
gastric cancer cells [57].
Conclusions
The present study exemplifies that calpain II play an es-
sential role in the modulation of GRP78 and regulationof ER stress-induced apoptosis in colon cancer. The
combination of AST with calpain inhibitors could ex-
hibit a more pronounced effect on ER stress-associated
apoptosis. These findings suggest a new therapeutic ap-
proach by targeting calpain and GRP in the treatment of
human colon cancer.
Additional file
Additional file 1: Figure S1. AST modulates the protein expression of
GRP in HT-29 colon cancer cells. HT-29 colon cancer cells were treated
with AST (80 μg/ml) for different time intervals (12–72 h). Specific antibodies
against GRP78 and GRP94 were used in Western immunoblotting to
detect the expression of different proteins. Data shown are representative
immunoblots with similar findings, normalized by β-actin. Blots were
scanned and optical densities were determined using the Quantity One
software.
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